http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5457126-A
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_7115ef17a0cce55f36229865e31ea6a0 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-275 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-275 |
| filingDate | 1994-03-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 1995-10-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5c219ed851d4304fa493d72b9f4a5b7f http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f697c38489cb38bc039d16327b1bc922 |
| publicationDate | 1995-10-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | US-5457126-A |
| titleOfInvention | Use of lodoxamide to treat ophthalmic allergic conditions |
| abstract | Disclosed are methods of using certain defined phenylene dioxamic acids in treating allergic ocular responses, such as, hayfever, conjunctivitis, atopic and keratoconjunctivitis, vernal conjunctivitis, giant capillary conjunctivitis and other diseases where mast cell degranulation are important in the etiology, by topical administration of said active to the affected eye; also disclosed are pharmaceutical compositions comprising said actives. |
| priorityDate | 1986-11-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 42.